Market Cap 7.49M
Revenue (ttm) 0.00
Net Income (ttm) -4.51M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 38,000
Avg Vol 79,150
Day's Range N/A - N/A
Shares Out 3.80M
Stochastic %K 85%
Beta -0.24
Analysts Sell
Price Target $28.00

Company Profile

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-pe...

Industry: Biotechnology
Sector: Healthcare
Phone: 844 722 6333
Address:
3480 Peachtree Road NE, Second Floor, Suite 103, Atlanta, United States
_Crocodileteeth
_Crocodileteeth Feb. 24 at 12:28 AM
Special thanks to @SqueezeSharkie for nailing that trade, He is worth Following for sure 💯 $NESR $WORX $AG $ALZN On watch
0 · Reply
hiwatt
hiwatt Feb. 23 at 6:52 PM
$ALZN Looks like we picked up another institution today, Virtu Financial bought 12,582 shares pushing total to 245,648 with a MRQ of 68.19%.
0 · Reply
hiwatt
hiwatt Feb. 22 at 8:11 PM
$ALZN The last clinical trial update submitted that met QC criteria was on 12-5 which was a 2 month 10 day delay according to the estimated time frame. It's been 2 months 17 days which puts us in the 30 days final results window. If you use the 11-19 date that they announced clinical trial completion and add 2 months 17 days, then you're at 2-5. Add 30 days to that because that is what the originally estimated then you're at March 5th, some I'm thinking next 2 weeks on clinical trial results.
1 · Reply
TradingFlow_
TradingFlow_ Feb. 20 at 12:13 PM
$ALZN run it up again plz
1 · Reply
edgardod
edgardod Feb. 19 at 6:35 PM
$ALZN open anew position
0 · Reply
ADKHighPeaks
ADKHighPeaks Feb. 19 at 4:13 AM
0 · Reply
ADKHighPeaks
ADKHighPeaks Feb. 19 at 4:12 AM
$ALZN boomshakalaka!
0 · Reply
LesterDiamond99
LesterDiamond99 Feb. 18 at 6:57 PM
1 · Reply
hiwatt
hiwatt Feb. 18 at 5:50 PM
$ALZN Some 65K shares traded this morning in 5 minutes. Either shorts covering or institution buying. Anyway, the pendulum is swinging
0 · Reply
TradeOperations
TradeOperations Feb. 18 at 4:35 PM
$ALZN Alzamend Neuro develops treatments for neurodegenerative diseases. Clinical validation is required. Cash runway is critical.
0 · Reply
Latest News on ALZN
Alzamend Neuro Announces Reverse Stock Split

May 8, 2025, 8:00 AM EDT - 10 months ago

Alzamend Neuro Announces Reverse Stock Split


See Why Alzamend Neuro Stock Is Rallying On Thursday

Sep 30, 2021, 1:45 PM EDT - 4 years ago

See Why Alzamend Neuro Stock Is Rallying On Thursday


Why Alzamend Neuro Shares Are Surging Higher Today

Sep 30, 2021, 11:54 AM EDT - 4 years ago

Why Alzamend Neuro Shares Are Surging Higher Today


Alzamend Neuro, Inc. to Ring Nasdaq Opening Bell Today

Jul 12, 2021, 6:00 AM EDT - 5 years ago

Alzamend Neuro, Inc. to Ring Nasdaq Opening Bell Today


Alzamend Neuro Announces Pricing of Initial Public Offering

Jun 14, 2021, 5:49 PM EDT - 5 years ago

Alzamend Neuro Announces Pricing of Initial Public Offering


_Crocodileteeth
_Crocodileteeth Feb. 24 at 12:28 AM
Special thanks to @SqueezeSharkie for nailing that trade, He is worth Following for sure 💯 $NESR $WORX $AG $ALZN On watch
0 · Reply
hiwatt
hiwatt Feb. 23 at 6:52 PM
$ALZN Looks like we picked up another institution today, Virtu Financial bought 12,582 shares pushing total to 245,648 with a MRQ of 68.19%.
0 · Reply
hiwatt
hiwatt Feb. 22 at 8:11 PM
$ALZN The last clinical trial update submitted that met QC criteria was on 12-5 which was a 2 month 10 day delay according to the estimated time frame. It's been 2 months 17 days which puts us in the 30 days final results window. If you use the 11-19 date that they announced clinical trial completion and add 2 months 17 days, then you're at 2-5. Add 30 days to that because that is what the originally estimated then you're at March 5th, some I'm thinking next 2 weeks on clinical trial results.
1 · Reply
TradingFlow_
TradingFlow_ Feb. 20 at 12:13 PM
$ALZN run it up again plz
1 · Reply
edgardod
edgardod Feb. 19 at 6:35 PM
$ALZN open anew position
0 · Reply
ADKHighPeaks
ADKHighPeaks Feb. 19 at 4:13 AM
0 · Reply
ADKHighPeaks
ADKHighPeaks Feb. 19 at 4:12 AM
$ALZN boomshakalaka!
0 · Reply
LesterDiamond99
LesterDiamond99 Feb. 18 at 6:57 PM
1 · Reply
hiwatt
hiwatt Feb. 18 at 5:50 PM
$ALZN Some 65K shares traded this morning in 5 minutes. Either shorts covering or institution buying. Anyway, the pendulum is swinging
0 · Reply
TradeOperations
TradeOperations Feb. 18 at 4:35 PM
$ALZN Alzamend Neuro develops treatments for neurodegenerative diseases. Clinical validation is required. Cash runway is critical.
0 · Reply
topstockalerts
topstockalerts Feb. 18 at 1:09 PM
$ALZN strong watch at these levels
0 · Reply
hiwatt
hiwatt Feb. 18 at 12:45 PM
$ALZN Looks like picked up another institutional buyer with XTX Topco buying in with 12470 shares and Tower Research bumping their total up to 2081. That's right at a 60% increase increase in institutional shares qt over qt. Total percentage now sits at 6.13%
0 · Reply
hiwatt
hiwatt Feb. 17 at 7:24 PM
$ALZN Singles, patience young man. Do yourself a favor and look at the biotech Mnpr. They IPOd just a year before Alzn and raised about the same money. Fast forward a few years and they got below a dollar and did a reverse split. Some 6 years after IPO investors were screaming,"show me the money and where's the data" because the stock was trading at $1.44 even after the split. Then bam, news hits and stock jumps to around $5. Stock treads water for one year and they partner with big pharma and stocks goes to $32 overnight. Over the next year the stock hits $112. Today it trades around $60 on 6.6M shares with an average price target of $114. So yes, the wait and low stock price is just part of the deal. "IF" news is good, then happy days again!!!!
1 · Reply
SinglesOverHomeRun
SinglesOverHomeRun Feb. 17 at 5:33 PM
$ALZN brah! help yourself. do yourself a favor. all these studies mean nothing: data is what matters and they delayed it. whats taking so long? the more it is delayed, the skepticism gets larger.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 17 at 4:41 PM
$ALZN Current Stock Price: $1.64
0 · Reply
MochiMeerkat
MochiMeerkat Feb. 17 at 3:52 PM
<£>< $JAGX $HCTI $ALZN $BBAI on watch
0 · Reply
hiwatt
hiwatt Feb. 17 at 3:14 AM
$ALZN Here is a breakdown of the evidence: Potent Action: Studies indicate that lithium salicylate can produce sustained, therapeutic levels of lithium in the brain and blood for over 48 hours in animal models without the toxic, rapid peak associated with lithium carbonate. Superiority in Studies: A novel ionic cocrystal, lithium salicylate and proline (LISPRO), has been shown to be superior to both lithium salicylate (LS) and lithium carbonate (LC) in reducing Alzheimer’s-related pathologies in mice.
0 · Reply
hiwatt
hiwatt Feb. 17 at 3:07 AM
$ALZN Back in August when lithium orotate got all the national attention for a possible treatment for Alzheimer's, it was chosen to be studied out of 16 different forms of lithium. It was chosen because it was an organic salt as apposed to lithium carbonate which is an inorganic salt and because of it's reduced ionization and it's ability to possibly reduce amyloid sequestration. When you look at the chart below you see organic lithium salicylate is very close to orotate on the lowest conductance scale. Simple logic tells you lithium salicylate with it's anti inflammatory effect should perform just as good, if not better.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 14 at 12:26 AM
$ALZN RSI: 26.36, MACD: -0.1223 Vol: 0.23, MA20: 2.07, MA50: 2.12 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BALR0G
BALR0G Feb. 13 at 10:44 PM
$ALZN imo gonna break down to 1.20s. Anyone who thinks otherwise is foolish.
1 · Reply
hiwatt
hiwatt Feb. 13 at 8:14 PM
$ALZN Welcome aboard Morgan Stanley with your 18,000 shares. Now 5.79% and 220, 115 shares.
0 · Reply
Biotechtrdr
Biotechtrdr Feb. 13 at 5:38 PM
$ALZN Copied the below from Ad Hoc News after Chat GPT said this article was released on Feb 2/2026. Note, below states that ALZN will be participating in the AAIC conference Feb 23 ( will they release news then ?? ) Several near-term events are expected to influence the company's trajectory: Phase II Topline Results: The market awaits data from the Phase II clinical trial for AL001, a candidate therapy. Scientific Presentation: Alzamend Neuro will participate in the AAIC Neuroscience Next conference, scheduled for February 23-26, 2026. Pipeline Developments: Potential updates regarding study programs for bipolar disorder and major depressive disorder are anticipated. Shareholder Meeting: The annual general meeting of shareholders is set for April 17, 2026, and will be conducted in a virtual format.
1 · Reply